These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 22158681)
1. The final phase of polio eradication: new vaccines and complex choices. Cochi SL; Linkins RW J Infect Dis; 2012 Jan; 205(2):169-71. PubMed ID: 22158681 [No Abstract] [Full Text] [Related]
2. The final stages of the global eradication of polio. John TJ N Engl J Med; 2000 Sep; 343(11):806-7. PubMed ID: 10984572 [No Abstract] [Full Text] [Related]
7. [Possible method of eradication of poliomyelitis as an infection]. Seĭbil' VB; Malyshkina LP Zh Mikrobiol Epidemiol Immunobiol; 2012; (3):107-13. PubMed ID: 22830285 [TBL] [Abstract][Full Text] [Related]
8. Polio vaccines: WHO position paper – March, 2016. Wkly Epidemiol Rec; 2016 Mar; 91(12):145-68. PubMed ID: 27039410 [No Abstract] [Full Text] [Related]
9. Control of poliomyelitis: a continuing paradox. Horstmann DM J Infect Dis; 1982 Oct; 146(4):540-51. PubMed ID: 6288809 [No Abstract] [Full Text] [Related]
10. Rapid and accurate identification of poliovirus strains used for vaccine production. Nijst OE; Mouthaan JJ; Mekkes DR; Jusic E; van der Avoort HG; Metz B J Virol Methods; 2013 Apr; 189(1):189-95. PubMed ID: 23434540 [TBL] [Abstract][Full Text] [Related]
11. Safety and immunogenicity of inactivated poliovirus vaccine made from Sabin strains: a phase II, randomized, positive-controlled trial. Liao G; Li R; Li C; Sun M; Li Y; Chu J; Jiang S; Li Q J Infect Dis; 2012 Jan; 205(2):237-43. PubMed ID: 22158682 [TBL] [Abstract][Full Text] [Related]
13. Polio vaccines: WHO position paper, January 2014. Wkly Epidemiol Rec; 2014 Feb; 89(9):73-92. PubMed ID: 24707513 [No Abstract] [Full Text] [Related]
14. [Poliovirus immunology: vaccines, problems for the prevention/eradication and future interventions]. Fernández-Cruz Pérez E; Rodríguez-Sainz C Rev Esp Salud Publica; 2013; 87(5):443-54. PubMed ID: 24322281 [TBL] [Abstract][Full Text] [Related]
15. Decision analysis in planning for a polio outbreak in the United States. Jenkins PC; Modlin JF Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814 [TBL] [Abstract][Full Text] [Related]
16. Vaccine-Derived Polioviruses and Children with Primary Immunodeficiency, Iran, 1995-2014. Shaghaghi M; Shahmahmoodi S; Abolhassani H; Soleyman-Jahi S; Parvaneh L; Mahmoudi S; Chavoshzadeh Z; Yazdani R; Zahraei SM; Ebrahimi M; Eslamian MH; Tabatabaie H; Yousefi M; Kandelousi YM; Oujaghlou A; Rezaei N; Aghamohammadi A Emerg Infect Dis; 2016 Oct; 22(10):1712-9. PubMed ID: 27648512 [TBL] [Abstract][Full Text] [Related]
18. CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus. Yang C; Shi H; Zhou J; Liang Y; Xu H Vaccine; 2009 Nov; 27(47):6558-63. PubMed ID: 19729087 [TBL] [Abstract][Full Text] [Related]